Last updated on August 2018

A Phase2 of A-101 Topical Solution in Subjects With Common Warts


Brief description of study

The primary objective of this study is to evaluate the effectiveness of A-101 compared to vehicle when applied to 1 common target wart on the trunk or extremities.

Detailed Study Description

The primary objective of this study is to evaluate the effectiveness of A-101 compared to vehicle when applied to 1 common target wart on the trunk or extremities. The secondary objectives of this study are to evaluate the clinical effect of A-101 when applied to all treated warts (Target Warts plus Non-Target Warts), duration of response in all treated warts (Target Warts plus Non-Target Warts), and Safety of A-101.

Clinical Study Identifier: NCT03210337

Contact Investigators or Research Sites near you

Start Over

Judith Schnyder, MBA

Aclaris Investigational Site
Warren, MI United States
2.57miles